Results 261 to 270 of about 6,606,497 (285)

Post-Marketing Active Surveillance of Adverse Reactions Following Influenza Cell-Based Quadrivalent Vaccine: An Italian Prospective Observational Study

Vaccines, 2021
Francesco Paolo Bianchi, Silvio Tafuri, Pasquale Stefanizzi   +2 more
exaly  

Investigation of the predictors of the response to Iguratimod therapy: A post-hoc analysis of post-marketing surveillance study

Modern Rheumatology, 2020
Naoki Ishiguro
exaly  

Intussusception following rotavirus vaccine administration: Post-marketing surveillance in the National Immunization Program in Australia

Vaccine, 2011
Peter B. McIntyre, John Carlin, Elizabeth Elliott   +2 more
exaly  

Post market surveillance

2020
openaire   +1 more source

Safety and effectiveness of 24-week treatment with iguratimod, a new oral disease-modifying antirheumatic drug, for patients with rheumatoid arthritis: interim analysis of a post-marketing surveillance study of 2679 patients in Japan

Modern Rheumatology, 2017
Takao Fujii, Tsuneyo Mimori, Naoto Tamura   +2 more
exaly  

Safety and effectiveness of istradefylline in patients with Parkinson’s disease: interim analysis of a post-marketing surveillance study in Japan

Expert Opinion on Pharmacotherapy, 2018
Akihisa Mori, Makio Takahashi
exaly  

Post‐marketing surveillance of novel foods

Pediatric Allergy and Immunology, 2002
openaire   +2 more sources

Safety of the Xuesaitong injection in China: results from a large-scale multicentre post-marketing surveillance study in a real-world setting

Current Medical Research and Opinion, 2020
Xue-Min Gao
exaly  

Fatal adverse drug reactions of anticancer drugs detected by all-case post-marketing surveillance in Japan.

Japanese Journal of Clinical Oncology, 2015
Jinichi Mori, Tetsuya Tanimoto, M Kami
exaly  

Post Marketing Surveillance

Thatha Usha, Durga Prasad Thammisetty, Y. Samuel, Pattubala Monika, Dasari Monish Kumar   +4 more
openaire   +1 more source